Your browser doesn't support javascript.
loading
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.
Chung, J H; Pavlick, D; Hartmaier, R; Schrock, A B; Young, L; Forcier, B; Ye, P; Levin, M K; Goldberg, M; Burris, H; Gay, L M; Hoffman, A D; Stephens, P J; Frampton, G M; Lipson, D M; Nguyen, D M; Ganesan, S; Park, B H; Vahdat, L T; Leyland-Jones, B; Mughal, T I; Pusztai, L; O'Shaughnessy, J; Miller, V A; Ross, J S; Ali, S M.
Afiliação
  • Chung JH; Foundation Medicine, Inc., Cambridge. Electronic address: jchung@foundationmedicine.com.
  • Pavlick D; Foundation Medicine, Inc., Cambridge.
  • Hartmaier R; Foundation Medicine, Inc., Cambridge.
  • Schrock AB; Foundation Medicine, Inc., Cambridge.
  • Young L; Foundation Medicine, Inc., Cambridge.
  • Forcier B; Foundation Medicine, Inc., Cambridge.
  • Ye P; Avera Cancer Institute, Sioux Falls.
  • Levin MK; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas.
  • Goldberg M; Foundation Medicine, Inc., Cambridge.
  • Burris H; Sarah Cannon Research Institute, Nashville.
  • Gay LM; Foundation Medicine, Inc., Cambridge.
  • Hoffman AD; Eastchester Center for Cancer Care, Bronx.
  • Stephens PJ; Foundation Medicine, Inc., Cambridge.
  • Frampton GM; Foundation Medicine, Inc., Cambridge.
  • Lipson DM; Foundation Medicine, Inc., Cambridge.
  • Nguyen DM; Sutter Medical Group of the Redwoods, Santa Rosa.
  • Ganesan S; Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick.
  • Park BH; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore.
  • Vahdat LT; Weill Cornell Breast Center, Weill Cornell Medicine, New York.
  • Leyland-Jones B; Avera Cancer Institute, Sioux Falls.
  • Mughal TI; Foundation Medicine, Inc., Cambridge; Tufts University Medical Center, Boston.
  • Pusztai L; Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven.
  • O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas.
  • Miller VA; Foundation Medicine, Inc., Cambridge.
  • Ross JS; Foundation Medicine, Inc., Cambridge; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, USA. Electronic address: mailto:jross@foundationmedicine.com.
  • Ali SM; Foundation Medicine, Inc., Cambridge.
Ann Oncol ; 28(11): 2866-2873, 2017 Nov 01.
Article em En | MEDLINE | ID: mdl-28945887
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Biomarcadores Tumorais / Sequenciamento de Nucleotídeos em Larga Escala / Tomada de Decisão Clínica / DNA Tumoral Circulante / Mutação Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Biomarcadores Tumorais / Sequenciamento de Nucleotídeos em Larga Escala / Tomada de Decisão Clínica / DNA Tumoral Circulante / Mutação Idioma: En Ano de publicação: 2017 Tipo de documento: Article